Which research priorities for AD in 2024? Curative precision medicine vs preventive exposome-targeted medicine. Dear Colleagues, Dear Friends, In a recently published provocative perspective paper (DOI: 10.3389/fpubh.2024.1351732), Ian A. Myles, a NIH researcher, asks some good questions to our community which could help shaping our priorities. Currently, with the industry-led dramatic development of biologics and […]
Read More
Release of the 4th Davos declaration on AD and Allergy➜ DOI: 10.1111/all.16247The 2022 Forum is now published with its usual “Declaration” signed by all participants. Besides the mounting burden of AD, attributed to significant environmental and lifestyle changes, the Forum acknowledged the progress in understanding AD and in developing targeted therapies but recognized a gap in [...] Read More
Abstracts for oral and poster presentations will represent the core of the scientific program at this meeting. Abstracts pertaining to human atopic dermatitis and related fields including animal models are appropriate. Check out your submissions Register NOW!-25% Early bird rates are extended to Sep 10! Accepted Oral Presentation in the main program (in-person or remotely […]
Read More